Notice of Special Interest (NOSI): HEAL Initiative: Clinical Translation of Diagnostic and Therapeutic Devices via Blueprint MedTech |
NOT-NS-23-002 |
|
|
06/21/2024 |
|
Notice of Special Interest (NOSI): Improving Outcomes in Cancer Treatment-Related Cardiotoxicity |
NOT-CA-22-001 |
|
|
11/06/2024 |
|
HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment |
RFA-NS-22-034 (R01 Clinical Trial Not Allowed) |
R01 |
Clinical Trial Not Allowed |
12/07/2024 |
Rachel Altshuler, Ph.D. |
HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices |
RFA-NS-23-028 (RM1 Clinical Trial Optional) |
RM1 |
Clinical Trial Optional |
06/10/2025 |
Rachel Altshuler, Ph.D. |
HEAL Initiative: Understanding Individual Differences in Human Pain Conditions |
RFA-NS-24-021 (R01 - Clinical Trial Optional) |
R01 |
Clinical Trial Optional |
02/07/2025 |
Rachel Altshuler, Ph.D. |
HEAL Initiative: Studies to Enable Analgesic Discovery |
RFA-NS-25-012 (R61/R33 - Clinical Trial Not Allowed) |
R61, R33 |
Clinical Trial Not Allowed |
01/16/2027 |
Rachel Altshuler, Ph.D. |
HEAL Initiative Notice of Special Interest (NOSI): Development and Validation of Pain-Related Models and Endpoints to Facilitate Non-Addictive Analgesic Discovery |
NOT-NS-22-095 |
|
|
06/25/2025 |
Rachel Altshuler, Ph.D. |
Notice of Special Interest to Encourage Eligible NIH HEAL Initiative Awardees to Apply for PA-20-222: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) |
NOT-NS-20-107 |
|
Clinical Trial Not Allowed |
05/16/2024 |
|
HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices |
RFA-NS-23-003 (RM1 Clinical Trial Optional) |
RM1 |
Clinical Trial Optional |
06/10/2025 |
|
NCI Clinical and Translational Exploratory/Developmental Studies |
PAR-22-216 (R21 Clinical Trial Optional) |
R21 |
Clinical Trial Optional |
07/02/2025 |
Marjorie Perloff, M.D. |